Background The growing burden of non-communicable diseases (NCDs) in Europe has intensified the need for timely, comparable, and policy-relevant health indicators derived from increasingly heterogeneous health data ecosystems. The European Health Data Space (EHDS) represents a major policy initiative to facilitate the secondary use of health data while preserving privacy, security, and national data sovereignty. In this context, federated analytics can foster international comparisons without requiring the transfer of person-level data. Objectives This scoping review aimed to map federated analytical approaches relevant to the production of NCD indicators within the EHDS and to develop a conceptual framework linking distributed statistical methods, privacy-preserving infrastructures, and policy-oriented surveillance requirements. Materials and methods A scoping review was conducted following the PRISMA Extension for Scoping Reviews. Searches were structured into three complementary conceptual domains: (a) federated analytical approaches, (b) distributed statistical inference methods, and (c) governance and health-data infrastructures relevant to the EHDS. Searches were performed in PubMed, Scopus, and IEEE Xplore, for studies published between 2010–26. Records were exported with abstracts and full bibliographic metadata. Deduplication and metadata-aware merging were conducted across databases using DOI and normalized-title matching. Results We retrieved a total of 2,362 records, of which 1,285 were unique records and 104 were finally retained. The literature revealed a heterogeneous but rapidly expanding ecosystem of distributed analytical approaches. We identified three major domains: (1) distributed regression; (2) federated or distributed analytical infrastructures; and (3) privacy-preserving federated epidemiological analysis. Discussion An increasing range of solutions for federated analytics is available for policy-grade NCD indicators. Longitudinal and survival models remain methodologically complex because of covariance structures and globally coupled risk sets. A modular approach is needed to incorporate public-health intelligence and a dynamic set of interoperable tools in the EHDS, with the active support of a decentralized network of active stakeholders. Conclusion Federated analytics is shifting the paradigm from centralized data pooling to computation-to-data architectures. The successful implementation of NCD surveillance in the EHDS require integrating statistics with legal, IT, policy and governance mechanisms. The review outlined a conceptual framework that can couple technical innovation with the best architecture for public-health knowledge production.
Fabrizio Carinci, Stephen Fava, Iztok Štotl et al.· Frontiers in Public Health· 0 citations
BACKGROUND
Primary laminopathies are a heterogeneous group of rare diseases caused by nuclear lamina dysfunction due to pathogenic LMNA variants. However, despite their ubiquitous expression, LMNA variants have rarely been linked to chronic kidney disease (CKD). Here, we systematically investigate clinical implications and functional underpinnings of a distinct LMNA missense variant (lamin A/C p.(Arg349Trp)) that has sporadically been found in patients with a complex phenotype including lipodystrophy, proteinuria, and focal segmental glomerulosclerosis (FSGS).
METHODS
In clinical and functional terms, we compare lamin A/C Arg349Trp with missense changes at Arg482, the most common hotspot residue for type 2 familial partial lipodystrophy (FPLD2). In particular, we assess renal endpoints in corresponding patient cohorts and investigate disease-associated alterations in vitro.
RESULTS
In contrast to FPLD2 patients, individuals with lamin A/C Arg349Trp experience high-grade proteinuria and a rapid decline of glomerular filtration rate with kidney failure at a median age of 43 years. Mechanistically, we demonstrate that Arg349Trp associates with an abrogation of the structural interaction between lamin A/C and nucleoporin 155, nuclear pore complex aggregation, and an alteration of TGF-β1-dependent signaling.
CONCLUSIONS
While patients with Lamin A/C Arg482 missense changes are at very low risk for progressive CKD, patients harboring Arg349Trp show nephrotic range proteinuria and kidney failure in midlife. Hence, high-grade proteinuric kidney disease is genotype-specific and patients with the Arg349Trp substitution require early renoprotective intervention to potentially halt progression and prevent kidney failure.
FUNDING
German Research Foundation, project IDs 502928386, 445703531, and grants HA 9779/2-1, HA 6908/4-1, HA 6908/7-1, HA 6908/8-1, HA 6908/12-1.
Sebastian Sewerin, Charlotte Aurnhammer, Mohamed Hamed et al.· JCI Insight· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.